What are the possible causes of a low CD4+ T-cell count in an HIV-negative patient?

Causes of Low CD4 Count in HIV-Negative Patients

Low CD4+ T-cell counts in HIV-negative patients can result from idiopathic CD4 lymphocytopenia, severe infections (particularly tuberculosis and other respiratory infections), malignancies (especially lymphomas), immunosuppressive medications, autoimmune diseases, and malnutrition—with the most critical step being to confirm HIV-negative status and assess for opportunistic infections when CD4 counts fall below 200 cells/μL.

Primary Diagnostic Considerations

Idiopathic CD4 Lymphocytopenia (ICL)

This is a diagnosis of exclusion characterized by persistent CD4 counts <300 cells/μL without HIV infection or other identifiable causes 1, 2. ICL differs from HIV infection in several key ways:

• More stable CD4 counts over time (not progressively declining)
• Lower CD8+ T-cell counts compared to HIV patients
• Normal or slightly low immunoglobulin levels (versus elevated in HIV)
• No evidence of transmissible agent 3

The most common presentations include cryptococcal infections, persistent human papillomavirus infections, and non-tuberculous mycobacterial infections, typically manifesting in the third and fourth decades of life 1.

Severe Infections

Active tuberculosis is a major cause of transient CD4 lymphocytopenia in HIV-negative patients 4. Key findings include:

• CD4 counts correlate strongly with disease severity markers: low serum albumin, extensive pulmonary disease, low body-mass index, and low hematocrit
• Serum albumin is the best single predictor of low CD4 counts
• CD4 counts typically normalize within 1 month of appropriate tuberculosis treatment 4

Severe respiratory tract infections can cause marked CD4 depletion during acute illness 5.

Malignancies

Cancer treatments, particularly chemotherapy, commonly cause CD4 lymphocytopenia 6:

• Decreases in CD4 counts from cancer therapy don't necessarily reflect immune dysfunction but still predict increased risk for opportunistic infections
• Baseline CD4 counts in cancer patients (median ~320-356 cells/μL) are often reduced regardless of HIV status 7
• Lymphomas specifically can cause primary CD4 depletion

Medications and Immunosuppressive Therapy

Multiple agents cause CD4 depletion 2:

• Corticosteroids
• Chemotherapeutic agents
• Immunosuppressive drugs for transplantation or autoimmune disease

Autoimmune Diseases

Approximately 23% of ICL patients develop autoimmune conditions, most frequently systemic lupus erythematosus 1. The relationship is bidirectional—autoimmune diseases can cause CD4 lymphocytopenia, and CD4 lymphocytopenia predisposes to autoimmunity.

Critical Thresholds and Clinical Implications

When CD4 counts fall below 200 cells/μL, opportunistic infection risk increases dramatically 8, 9:

• Pneumocystis jiroveci pneumonia (PCP) prophylaxis should be initiated
• Consider prophylaxis for other opportunistic infections based on CD4 level

For CD4 counts <100 cells/μL 6:

• Add Mycobacterium avium complex (MAC) prophylaxis
• Consider dose reductions for chemotherapy if applicable

Diagnostic Workup Algorithm

1. Confirm HIV-negative status with appropriate testing (anti-HIV antibody, HIV RNA if indicated)

2. Repeat CD4 count to confirm persistent lymphocytopenia (ideally two measurements)

3. Assess for acute/severe infections:

   • Tuberculosis (PPD/IGRA, chest imaging, sputum studies)
   • Other respiratory infections
   • Opportunistic infections if CD4 <200 cells/μL

4. Evaluate for malignancy:

   • Complete blood count with differential
   • Peripheral smear
   • Consider imaging and bone marrow biopsy if indicated

5. Review medication history for immunosuppressive agents

6. Screen for autoimmune disease:

   • ANA, complement levels, disease-specific antibodies
   • Clinical features of SLE or other autoimmune conditions

7. Assess nutritional status and albumin level (strong predictor of CD4 depletion in infectious causes) 4

Management Principles

Prophylaxis thresholds mirror HIV guidelines 8, 1:

• CD4 <200 cells/μL: PCP prophylaxis (trimethoprim-sulfamethoxazole preferred, alternatives include dapsone or atovaquone)
• CD4 <100 cells/μL: Add MAC prophylaxis (azithromycin 1200 mg weekly)

For idiopathic cases:

• Frequent monitoring for opportunistic infections
• Consider prophylaxis based on CD4 level and presence of other infections
• Hematopoietic stem cell transplantation has been successful in severe cases 1

Common pitfall: Assuming all low CD4 counts in HIV-negative patients represent ICL without adequately evaluating for treatable causes like tuberculosis, where CD4 counts normalize with appropriate therapy 4.